Literature DB >> 12640040

Genome-wide expression screens indicate a global role for protein kinase CK2 in chromatin remodeling.

Thomas Barz1, Karin Ackermann, Gaelle Dubois, Roland Eils, Walter Pyerin.   

Abstract

Protein kinase CK2, a vital, pleiotropic and highly conserved serine/threonine phosphotransferase is involved in transcription-directed signaling, gene control and cell cycle regulation and is suspected to play a role in global processes. Searching for these global roles, we analyzed the involvement of CK2 in gene expression at cell cycle entry by using genome-wide screens. Comparing expression profiles of Saccharomyces cerevisiae wild-type strains with strains with regulatory or catalytic subunits of CK2 deleted, we found significant alterations in the expression of genes at all cell cycle phases and often in a subunit- and isoform-specific manner. Roughly a quarter of the genes known to be regulated by the cell cycle are affected. Functionally, the genes are involved with cell cycle entry, progression and exit, including spindle pole body formation and dynamics. Strikingly, most CK2-affected genes exhibit no common transcriptional control features, and a considerable proportion of temporarily altered genes encodes proteins involved in chromatin remodeling and modification, including chromatin assembly, (anti-)silencing and histone (de-)acetylation. In addition, various metabolic pathway and nutritional supply genes are affected. Our data are compatible with the idea that CK2 acts at different levels of cellular organization and that CK2 has a global role in transcription-related chromatin remodeling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640040     DOI: 10.1242/jcs.00352

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  26 in total

Review 1.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

2.  Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.

Authors:  Ferdinand Kappes; Catalina Damoc; Rolf Knippers; Michael Przybylski; Lorenzo A Pinna; Claudia Gruss
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  CK2 phosphorylation of eukaryotic translation initiation factor 5 potentiates cell cycle progression.

Authors:  Miwako Kato Homma; Ikuo Wada; Toshiyuki Suzuki; Junko Yamaki; Edwin G Krebs; Yoshimi Homma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-14       Impact factor: 11.205

4.  A global view of CK2 function and regulation.

Authors:  Allison Poole; Tim Poore; Sricharan Bandhakavi; Richard O McCann; David E Hanna; Claiborne V C Glover
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

5.  Potential interface between ribosomal protein production and pre-rRNA processing.

Authors:  Dipayan Rudra; Jaideep Mallick; Yu Zhao; Jonathan R Warner
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

6.  Protein kinase CK2 holoenzyme promotes start-specific transcription in Saccharomyces cerevisiae.

Authors:  Farida Tripodi; Raffaele Nicastro; Sara Busnelli; Claudia Cirulli; Elisa Maffioli; Gabriella Tedeschi; Lilia Alberghina; Paola Coccetti
Journal:  Eukaryot Cell       Date:  2013-07-19

7.  Is there a link between protein kinase CK2 and auxin signaling?

Authors:  Jordi Moreno-Romero; M Carmen Martínez
Journal:  Plant Signal Behav       Date:  2008-09

8.  CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research.

Authors:  Silvio E Perea; Idania Baladron; Yanelda Garcia; Yasser Perera; Adlin Lopez; Jorge L Soriano; Noyde Batista; Aley Palau; Ignacio Hernández; Hernán Farina; Idrian Garcia; Lidia Gonzalez; Jeovanis Gil; Arielis Rodriguez; Margarita Solares; Agueda Santana; Marisol Cruz; Matilde Lopez; Carmen Valenzuela; Osvaldo Reyes; Pedro A López-Saura; Carlos A González; Alina Diaz; Lila Castellanos; Aniel Sanchez; Lazaro Betancourt; Vladimir Besada; Luis J González; Hilda Garay; Roberto Gómez; Daniel E Gómez; Daniel F Alonso; Phillipe Perrin; Jean-Yves Renualt; Hugo Sigman; Luis Herrera; Boris Acevedo
Journal:  Mol Cell Biochem       Date:  2011-07-07       Impact factor: 3.396

Review 9.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

10.  Identification and characterization of a novel testis-specific gene CKT2, which encodes a substrate for protein kinase CK2.

Authors:  Xiyuan Bai; Derek Silvius; Edward D Chan; Denise Escalier; Shaun Xin Xu
Journal:  Nucleic Acids Res       Date:  2009-03-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.